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Abstract
OBJECTIVE: To retrospectively study the preva-
lence of fatigue and factors associated with fatigue
among acquired immunodeficiency syndrome
(AIDS) patients with antiretroviral drug adverse re-
actions.
METHODS: Data were collected from case report
forms (CRFs) for a project funded by the 11th Na-
tional 5-year Special Science and Technology Pro-
gram on Major Infectious Diseases. Fatigue was de-
fined by patient self-report. The outcomes were the
prevalence of fatigue and the potential risk factors
of fatigue. Univariate and multivariate logistic re-
gression analyses were conducted to identify the
factors associated with fatigue.
RESULTS: Among the 228 subjects, the prevalence
of fatigue was 86.8%. In univariate analysis, the sig-
nificant differences in demographic characteristics
between patients with and without fatigue were:
gender [OR=2.29; 95% CI (1.05-4.98)], education lev-
el [OR=0.40; 95% CI (0.18-0.85)], anemia [OR=3.80;
95% CI (1.27-11.31)], time of HIV diagnosis [OR=
0.29; 95% CI (0.13-0.65)], and route of infection [OR=
0.14; 95% CI (0.06-0.32)]. Abnormal taste and rapid
pulse were more commonly seen in patients with
fatigue (P<0.05), while abdominal distension and
lumbar soreness were encountered less often in pa-
tients with fatigue (P<0.05). Multivariate analysis
showed that the four main factors associated with
fatigue were anemia [OR=3.50; 95% CI (1.01-12.15)],
route of infection [OR=3.40; 95% CI (1.21-9.58); P=
0.02<0.05], lumbar soreness [OR=0.06; 95% CI
(0.02-0.18); P=0.000<0.05], and rapid pulse [OR=
10.58; 95% CI (2.16-51.75); P=0.004<0.05].
CONCLUSION: This study demonstrated that fa-
tigue is common (86.8% prevalence) in AIDS pa-
tients with antiretroviral drug adverse reactions,
and that anemia, route of infection (i.e., non-com-
mercial blood donation) and rapid pulse were risk
factors, while lumbar soreness was a protective fac-
tor related to fatigue. More attention should be
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paid to fatigue and more efforts should be made to
find ways to prevent, control and eliminate this
symptom in AIDS patients with antiretroviral drug
adverse reactions.
© 2013 JTCM. All rights reserved.
Key words: Retrospective studies; Acquired immu-
nodeficiency syndrome; HIV; Anemia; Fatigue
INTRODUCTION
Acquired immunodeficiency syndrome (AIDS), caused
by the human immunodeficiency virus (HIV), has be-
come a major public health problem in China1 since
1985, the year that the first Chinese HIV/AIDS case
was reported by the Peking Union Medical College
Hospital in Beijing.2
Fatigue is the status of subjective tiredness, and affects
nearly 10% of the general population worldwide.3 It is
also a common symptom among the HIV/AIDS pa-
tients.4 Researchers have paid close attention to this
troublesome symptom.5 According to the literature, fa-
tigue may result in patients' poor adherence to medica-
tions, poor effects from medical treatment and care, in-
creased drug resistance, lowered quality of life, and in-
creased morbidity and mortality.6-8 In addition, reliev-
ing fatigue can improve the quality of life of and re-
duce mental depression in patients.9
In this retrospective study, the prevalence and risk fac-
tors of self-reported fatigue were analyzed among
AIDS patients with antiretroviral drug adverse reac-
tions.
MATERIALS ANDMETHODS
Study design and data collection
A retrospective study was conducted at the First Hospi-
tal Affiliated to Henan College of Traditional Chinese
Medicine, Zhengzhou, China. The data were collected
from case report forms (CRFs) that had been complet-
ed in 2010 for a project of the 11th National 5-year
Special Science and Technology Program on Major In-
fectious Diseases.
The case inclusion criteria were that the baseline data
were recorded and available, and the intact informed
consent forms were signed. Patients with abnormal val-
ues or missing data for renal function, liver function,
or CD4+ T-cell counts were excluded.
The data included three sections: general information,
clinical signs and symptoms, and laboratory findings.
General information included age, gender, marital sta-
tus, level of education, occupation, route of HIV infec-
tion, time of commencement of antiretroviral treat-
ment, personal history of disease, and obstetrical histo-
ry. The signs and symptoms collected from the original
case reports were fatigue, shortness of breath, a feeling
of tightness in the chest, dizziness, poor appetite, ab-
dominal distension, lumbar soreness, abnormal urina-
tion and defecation, sleeplessness, abnormal taste, dis-
tending pain in the hypochondrium, headache,
waist-leg weakness, abnormal sweating, pulse condi-
tion, and tongue image. The laboratory findings in-
cluded CD4+ T-cell counts and hemoglobin counts.
Definitions
All signs and symptoms were described according to
Zhong Yi Lin Chuang Zhen Liao Shu Yu (2007)10 and
Terms in Traditional Chinese Medicine and Pharmacy
(2005).11
Fatigue was self-reported by patients, and was divided
into three degrees: mild (lower energy and somewhat
lowered physical activity), moderate (mental weariness
and much lower physical activity), and severe (extreme
tiredness, daily activities can hardly be completed).
Outcomes
The outcomes were the prevalence and the potential
factors associated with self-reported fatigue.
Statistical methods
The SPSS 19.0 software package (SPSS Inc., Chicago,
IL, USA) was used for statistical analyses. We described
the patients' characteristics as means ± standard devia-
tion (SD) and frequencies (% ). Categorical variables
were compared using the Chi-square test or Fisher's ex-
act test. Continuous variables were compared using the
students' t-test or Mann-Whitney test. Analysis of the
clinical and demographic factors associated with self-re-
ported fatigue was performed for all patients to avoid
bias associated with the likelihood of performing a test.
Factors considered relevant and associated with fatigue
in univariate analysis at P<0.10 were included in the
multivariate model, and P<0.05 was considered statisti-
cally significant.
RESULTS
General demographic characteristics
Of the 228 cases analyzed in this study, 40.4% were
male and 59.6% female. The mean age was 46.0 (SD,
8.1). A total of 193 patients (84.6% ) were infected
with HIV from commercial blood donations. All pa-
tients received antiretroviral drugs free from the local
government. A total of 151 patients (66.2%) were illit-
erate or graduated from primary school or junior mid-
dle school, and 77 patients (33.8%) graduated from se-
nior middle school. A total of 173 patients (75.9% )
were married, and 55 patients (24.1%) were either di-
vorced, widowed, or single. The median CD4 + T-cell
count was 147.5 cells/mm3 (range: 3-729 cells/mm3).
Among the 228 patients, 198 patients (86.8% ) com-
plained of fatigue (79 mild cases, 87 moderate cases,
and 32 severe cases). The statistically significant differ-
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ences in general demographic characteristics between
those with and without fatigue were: gender [OR=
2.29; 95% CI (1.05-4.98)], education level [OR=0.39;
95% CI (0.18-0.85)], anemia [OR=3.80; 95% CI
(1.27-11.31)], time of HIV diagnosis [OR=0.29; 95%
CI (0.13-0.65)] and route of infection [OR=0.14; 95%
CI (0.06-0.32)] (Table 1).
Comparison of symptoms between patients with and
without fatigue
In the 228 patients, the signs and symptoms with inci-
dences exceeding 10% were as follows: shortness of
breath, a feeling of tightness in the chest, dizziness,
poor appetite, abdominal distension, lumbar soreness,
sleeplessness, abnormal taste, pain in the hypochondri-
um, headache, waist-leg weakness, abnormal sweating,
light red tongue, deep pulse, rapid pulse and thready
pulse. The proportions of some signs and symptoms
differed between patients with and without fatigue. Ab-
normal taste and rapid pulse were more commonly
seen in those with fatigue (P<0.05), but abdominal dis-
tension and lumbar soreness were encountered less in
those with fatigue (P<0.05) (Table 2).
Logistic regression analysis of risk factors associated
with fatigue
We conducted logistic regression analysis to determine
risk factors associated with fatigue. The dependent vari-
able was fatigue (yes vs no), and the independent vari-
ables were gender, education level, anemia, HIV con-
firmed time, route of infection, lumbar soreness, ab-
dominal distension, rapid pulse, abnormal taste,
thready pulse and light red tongue. Education level was
defined as either junior middle school or below versus
senior middle school or above; time of HIV diagnosis
was defined as either before or after 2004; and, the
route of infection was defined as either commercial
blood donation or other. The four factors associated
with fatigue were anemia [OR=3.50; 95% CI
(1.01-12.15); P=0.05<0.05], route of infection [OR=
3.40; 95% CI (1.21-9.58); P=0.02<0.05], lumbar sore-
ness [OR=0.06; 95% CI (0.02-0.18); P=0.00<0.05],
Variable
Age (years)
≤44
≥45
Gender
Male
Female
Marital state
Married
Divorced, widowed or single
Education level
Junior middle school or below
Senior middle school or above
CD4T (cell /mm3)
≤199
≥200
Anemiaa
No
Yes
Time of HIV diagnosis
Before the year 2004
After the year 2004
Route of infection
Commercial blood donation
Others
Studied case
(n=228)
106 (46.5)
122 (53.5)
89 (39.0)
139 (61.0)
173 (75.9)
55 (24.1)
151 (66.2)
77 (33.8)
153 (67.1)
75 (32.9)
151 (66.2)
77 (33.8)
168 (73.7)
60 (26.3)
193 (84.6)
35 (15.4)
Without fatigue
(n=30)
16 (53.3)
14 (46.7)
17 (56.7)
13 (43.3)
23 (76.7)
7 (23.3)
14 (46.7)
16 (53.3)
19 (63.3)
11 (66.6)
26 (86.7)
4 (13.3)
15 (50.0)
15 (50.0)
16 (53.3)
14 (46.7)
With fatigue
(n=198)
90 (45.5)
108 (54.5)
72 (36.4)
126 (63.6)
150 (75.8)
48 (24.2)
137 (69.2)
61 (30.8)
134 (67.7)
64 (32.3)
125 (63.1)
73 (36.9)
153 (77.3)
45 (22.7)
177 (89.4)
21 (10.6)
OR
(95% CI)
1.37 (0.64-2.96)
2.29 (1.05-4.98)
1.05 (0.52-2.60)
0.39 (0.18-0.85)
0.82 (0.37-1.84)
3.80 (1.27-11.31)
0.29 (0.13-0.65)
0.14 (0.06-0.32)
P value
0.439
0.034
0.914
0.015
0.637
0.012
0.002
0.000
Table 1 Demographic characteristics of the patients [n (%)]
Note: aHemoglobin level below 12 g/dL (male) or below 11 g/dL (female).
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and rapid pulse [OR=10.58; 95% CI (2.16-51.75); P=
0.004<0.05]. Anemia, route of infection and rapid
pulse were risk factors, while lumbar soreness was a pro-
tective factor (Table 3).
DISCUSSION
Morbidity and mortality of HIV-infected patients have
been greatly lowered by highly active anti-retroviral
therapy (HAART), but the prevalence of HIV-related
and non-HIV-related diseases and symptoms have in-
creased in HIV-infected patients.12 Recently, symptoms
are more apt to be due to adverse effects of antiretrovi-
ral drugs, rather than symptoms induced by co-morbid
diseases and poorly understood complications due to
the long-standing HIV disease.
Fatigue is a common subjectively experienced symp-
tom of HIV/AIDS patients. Epidemiology research of
fatigue among HIV/AIDS patients has reported that
HIV-related fatigue is reported in 33%-88% of the pa-
tients.13 However, research on HIV-related fatigue is sel-
dom published in China.
We found that among 228 AIDS patients with antiret-
roviral drug adverse reactions, 198 cases reported fa-
tigue, with an prevalence of 86.8% . In addition, our
retrospective study showed that the prevalence of fa-
tigue was higher among HIV/AIDS patients with anti-
retroviral drug adverse reactions than among the gener-
al population.
The factors that influence the occurrence of fatigue
among HIV/AIDS patients are complicated and still
unclear. For example, some researchers report that age,
gender, AIDS stage, CD4+ T-cell count, HAART, psy-
chological functions, and patients in different geo-
graphic regions are important factors,14,15 but others
have reported different results.16,17
It is well known that patients with antiretroviral drug
adverse reactions may have many symptoms along with
fatigue, such as fever, gastrointestinal symptoms,
breathing difficulties, limb numbness, and insomnia.
Symptom and sign
Shortness of breath
A feeling of tightness in the chest
Dizziness
Poor appetite
Abdominal distension
Lumbar soreness
Sleeplessness
Abnormal taste
Pain in hypochondrium
Headache
Waist-leg weakness
Abdominal sweating
Light red tongue
Deep pulse
Rapid pulse
Thready pulse
Studied case
(n=228)
99 (43.4)
153 (67.1)
197 (86.1)
34 (14.9)
116 (50.9)
75 (32.9)
96 (42.1)
162 (71.1)
90 (39.5)
109 (47.8)
106 (46.5)
100 (43.9)
87 (38.2)
77 (33.8)
54 (23.7)
55 (24.1)
Without fatigue
(n=30)
10 (33.3)
17 (56.7)
27 (90.0)
5 (16.7)
24 (80.0)
25 (83.3)
9 (30.0)
16 (53.3)
10 (33.3)
18 (60.0)
17 (56.7)
15 (50.0)
7 (23.3)
12 (40.0)
2 (6.7)
3 (10.0)
With fatigue
(n=198)
89 (44.49)
136 (59.6)
170 (74.6)
29 (14.6)
92 (46.5)
50 (25.3)
87 (43.9)
146 (73.7)
80 (40.4)
91 (46.0)
89 (44.9)
85 (42.9)
80 (40.4)
65 (32.8)
52 (26.3)
52 (26.3)
χ2
1.431
1.705
0.380
0.084
11.723
39.814
2.077
5.273
0.545
2.058
1.438
0.529
3.217
0.599
2.347
1.936
P value
0.232
0.192
0.537
0.772
0.001
0.000
0.150
0.022
0.460
0.151
0.230
0.467
0.073
0.439
0.020
0.066
Table 2 Comparison of signs and symptoms between patients with and without fatigue [n (%)]
Anemia
Route of infection
Lumbar soreness
Rapid pulse
Constant
B
1.253
1.225
-2.816
2.359
1.868
SE
0.635
0.528
0.559
0.810
0.625
χ2
3.897
5.385
25.403
8.474
8.947
P value
0.048
0.020
0.000
0.004
0.003
OR (95% CI)
3.50 (1.01-12.15)
3.40 (1.21-9.58)
0.06 (0.02-0.18)
10.57 (2.16-51.75)
-
Table 3 Logistic regression analysis of factors associated with fatigue
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We found that some of the symptoms were different
between patients with and without fatigue. Abnormal
taste and rapid pulse were more commonly seen in
those with fatigue (P<0.05). By multivariate logistic re-
gression analysis, rapid pulse [OR=10.58; 95% CI
(2.16-51.75); P=0.004<0.05] was more likely to occur
in patients with fatigue, but lumbar soreness [OR=
0.06; 95% CI (0.02-0.18); P=0.00<0.05] more often
appeared in those without fatigue.
There are conflicting reports in the literature regarding
the relationship between CD4 + T-cell count and fa-
tigue, because some studies have confirmed the rela-
tion18 but the others have denied it.19 In our study, us-
ing univariate analysis we found no statistically signifi-
cant difference in CD4+ T-cell counts between the two
groups.
The occurrence of anemia increases with HIV stage.20
Anemia is a common and prognostic marker of disease
progression, and anemia is independent of CD4 +
T-cell counts and viral load.21 HAART is associated
with a significant improvement in hemoglobin lev-
els.22 In our study, the prevalence of anemia was
33.8% , and there was a significant difference be-
tween those with fatigue (36.9%) and those without
fatigue (13.3% ). More importantly, anemia was a
risk factor [OR=3.50; 95% CI (1.01-12.15)] related
to fatigue among the AIDS patients with antiretrovi-
ral during adverse reactions.
It has not been reported whether the route of infection
is one cause of fatigue. However, we found that the
route of infection was a risk factor [OR=3.40; 95% CI
(1.21-9.58)] of fatigue among AIDS patients with anti-
retroviral drug adverse reactions. This needs further
study.
The present study showed that fatigue among AIDS pa-
tients with antiretroviral drug adverse reactions was
common, and the prevalence was 86.8%. This study al-
so demonstrated that anemia, route of infection (i.e.,
non-commercial blood donation) and rapid pulse were
risk factors, while lumbar soreness was a protective fac-
tor of fatigue among AIDS patients with antiretroviral
drug adverse reactions.
Furthermore, it should be noted that at present there is
no specific treatment for fatigue among AIDS patients.
Traditional Chinese Medicine, one of the important
parts of complementary and alternative medicine, has
shown efficacy for treatment of many diseases, and has
been used for treatment of AIDS and its complications
in the last three decades.23,24 This may be an opportuni-
ty for Chinese medicine practitioners to find treatment
methods to conquer fatigue.
In conclusion, fatigue is a common symptom; howev-
er, more attention should been paid to fatigue in HIV/
AIDS patients, and more efforts should be made for
better control and treatment of fatigue in AIDS pa-
tients, to improve patients' quality of life.
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